Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment
Tae-Ok Kim, Hong-Joon Shin, Yu-Il Kim, Sung-Chul Lim, Young-Il Koh, Yong-Soo Kwon
Korean J Intern Med. 2019;34(5):1050-1057. Published online 2019 Mar 19 DOI: https://doi.org/10.3904/kjim.2018.063
Citations to this article as recorded by 
Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations
Gozde Koycu Buhari, Ferda Oner Erkekol, Ilkay Koca Kalkan, Hale Ates, Gurgun Tugce Vural Solak, Ozgur Akkale, Kurtulus Aksu
World Allergy Organization Journal.2024; 17(1): 100862. CrossRef
Adverse Drug Reactions Related to Treatment of Drug-Susceptible Tuberculosis in Brazil: A Prospective Cohort Study
Flávia M. Sant´Anna, Mariana Araújo-Pereira, Carolina A. S. Schmaltz, María B. Arriaga, Raquel V. C. de Oliveira, Bruno B. Andrade, Valeria C. Rolla
Frontiers in Tropical Diseases.2022;[Epub] CrossRef
Hypersensitivity reactions to multiple anti-tuberculosis drugs
Hong-Joon Shin, Jin-Sun Chang, Min-Suk Kim, Bo-Gun Koh, Ha-Young Park, Tae-Ok Kim, Chul-Kyu Park, In-Jae Oh, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Young-Il Koh, Yong-Soo Kwon, Walter R. Taylor
PLOS ONE.2021; 16(2): e0246291. CrossRef
High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs
Da Woon Sim, Hye Su You, Ji Eun Yu, Young-Il Koh
World Allergy Organization Journal.2021; 14(7): 100562. CrossRef